BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought
Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of ...
Medscape13 天
Differing Clinical Impact of BRCA1 and BRCA2 Mutations in Serous Ovarian Cancer
Pharmacogenomics. 2012;13(13):1523-1535. 5-year survival for stage III and IV (%): carriers, 38.1; noncarriers, 24.5 Median survival: p = 0.002 5-year survival for stage III and IV: p < 0.001 [46 ...
Armed robbery in Revesby7 天
BRCA1 Gene Mutations Not Key to Prostate Cancer Start
Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as ...
MedPage Today7 天
BRCA1 Contribution to Prostate Cancer Called Into Question
Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
News Medical on MSN7 天
Study challenges role of BRCA1 mutation in prostate cancer initiation
Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...
Research upends scientific understanding of how anticancer drugs work
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
EurekAlert!14 天
Unlocking breast cancer treatments with liquid biopsy
A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high ...
News Medical14 天
Study shows ctDNA testing could revolutionize breast cancer treatment
Mutations in BRCA1 and BRCA2 were found in 6% and 8% of patients, respectively, while 12% of patients exhibited ESR1 mutations. These findings underscore the potential of ctDNA as a valuable biomarker ...